Drug Type Small molecule drug |
Synonyms Orinidazole, Ornidazole (USAN/INN), RO-07-0207 + [3] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 2001), |
Regulation- |
Molecular FormulaC7H10ClN3O3 |
InChIKeyIPWKIXLWTCNBKN-UHFFFAOYSA-N |
CAS Registry16773-42-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Amebiasis | CN | 01 Jan 2001 | |
Anaerobic bacterial infection | CN | 01 Jan 2001 | |
Giardiasis | CN | 01 Jan 2001 | |
Trichomonas Infections | CN | 01 Jan 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dysentery, Amebic | Phase 1 | CN | - | 10 Oct 2013 |
Liver Abscess, Amebic | Phase 1 | CN | - | 10 Oct 2013 |
Urogenital infection by Trichomonas vaginalis | Phase 1 | CN | - | 10 Oct 2013 |
Not Applicable | 82 | Ornidazole alone | vjvvrkqhbw(izfioblfbw) = mmjoyghcxm azqlnnkeje (hkjphbqece ) View more | - | 10 Nov 2023 |